Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Arch Ital Urol Androl ; 93(1): 71-76, 2021 Mar 19.
Article in English | MEDLINE | ID: covidwho-1146951

ABSTRACT

This collection of cases describes some unusual urological tumors and complications related to urological tumors and their treatment. Case 1: A case of uretero-arterial fistula in a patient with long-term ureteral stenting for ureteral oncological stricture and a second case associated to retroperitoneal fibrosis were described. Abdominal CT, pyelography, cystoscopy were useful to show the origin of the bleeding. Angiography is useful for confirming the diagnosis and for subsequent positioning of an endovascular prosthesis which represents a safe approach with reduced post-procedural complications. Case 2: A case of patient who suffered from interstitial pneumonitis during a cycle of intravesical BCG instillations for urothelial cancer. The patient was hospitalized for more than two weeks in a COVID ward for a suspected of COVID-19 pneumonia, but he did not show any evidence of SARS-CoV-2 infection during his hospital stay. Case 3: A case of a young man with a functional urinary bladder paraganglioma who was successfully managed with complete removal of the tumor, leaving the urinary bladder intact. Case 4: A case of a 61 year old male suffering from muscle invasive bladder cancer who was admitted for a radical cystectomy and on the eighth postoperative day developed microangiopathic hemolytic anemia and thrombocytopenia, which clinically defines thrombotic microangiopathy.


Subject(s)
Urologic Neoplasms/therapy , Administration, Intravesical , Adult , BCG Vaccine/therapeutic use , COVID-19/complications , COVID-19/therapy , Carcinoma, Transitional Cell/pathology , Computed Tomography Angiography , Cystectomy , Fistula/complications , Fistula/therapy , Humans , Male , Middle Aged , Paraganglioma/surgery , Paraganglioma/therapy , Pneumonia/complications , Pneumonia/therapy , Postoperative Complications/therapy , Purpura, Thrombotic Thrombocytopenic/etiology , Purpura, Thrombotic Thrombocytopenic/therapy , Ureteral Diseases/complications , Ureteral Diseases/diagnostic imaging , Ureteral Diseases/therapy , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/therapy , Urologic Neoplasms/complications , Urologic Neoplasms/diagnostic imaging
2.
Food Chem Toxicol ; 141: 111418, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-345861

ABSTRACT

Occupational, residential, dietary and environmental exposures to mixtures of synthetic anthropogenic chemicals after World War II have a strong relationship with the increase of chronic diseases, health cost and environmental pollution. The link between environment and immunity is particularly intriguing as it is known that chemicals and drugs can cause immunotoxicity (e.g., allergies and autoimmune diseases). In this review, we emphasize the relationship between long-term exposure to xenobiotic mixtures and immune deficiency inherent to chronic diseases and epidemics/pandemics. We also address the immunotoxicologic risk of vulnerable groups, taking into account biochemical and biophysical properties of SARS-CoV-2 and its immunopathological implications. We particularly underline the common mechanisms by which xenobiotics and SARS-CoV-2 act at the cellular and molecular level. We discuss how long-term exposure to thousand chemicals in mixtures, mostly fossil fuel derivatives, exposure toparticle matters, metals, ultraviolet (UV)-B radiation, ionizing radiation and lifestyle contribute to immunodeficiency observed in the contemporary pandemic, such as COVID-19, and thus threaten global public health, human prosperity and achievements, and global economy. Finally, we propose metrics which are needed to address the diverse health effects of anthropogenic COVID-19 crisis at present and those required to prevent similar future pandemics.


Subject(s)
Air Pollutants/toxicity , Betacoronavirus , Coronavirus Infections/epidemiology , Pesticides/toxicity , Pneumonia, Viral/epidemiology , Xenobiotics/toxicity , Animals , Antiviral Agents/therapeutic use , COVID-19 , Coronavirus Infections/drug therapy , Coronavirus Infections/physiopathology , Diet , Epidemics , Humans , Immune System/drug effects , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/physiopathology , Prevalence , Receptors, Aryl Hydrocarbon/metabolism , Risk Factors , SARS-CoV-2 , Signal Transduction/drug effects , Time
SELECTION OF CITATIONS
SEARCH DETAIL